A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC

NCT00144989 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

281

Enrollment

OTHER

Sponsor class

Conditions

Small-Cell-Lung Cancer

Interventions

DRUG: Etoposide and cisplatin after chemoradiotherapy
DRUG: Irinotecan and cisplatin after chemoradiotherapy

Sponsor

Haruhiko Fukuda

Collaborators

[object Object]